首页|EECP联合强化降脂对PCI术后患者的临床疗效及对残余炎症因子的影响

EECP联合强化降脂对PCI术后患者的临床疗效及对残余炎症因子的影响

扫码查看
目的 观察增强型体外反搏(EECP)联合强化降脂对经皮冠状动脉介入(PCI)术后患者的临床疗效及对残余炎症因子的影响.方法 选取2021年6月至2023年6月在郑州大学第二附属医院心血管内科就诊的符合纳入标准的患者150例.随机分为A、B、C 3组,每组50例.A组接受常规药物治疗,B组接受常规药物治疗联合强化降脂治疗,C组接受常规药物治疗、强化降脂治疗联合EECP治疗.比较3组患者治疗后的临床效果、活动耐量、心脏射血功能及残余炎症因子的变化情况.结果 治疗后,3组患者的心绞痛每周发作频率、持续时间、残余炎症因子超敏C-反应蛋白及脂蛋白相关性磷脂酶A2水平均低于治疗前,且C组各项指标低于A、B组,差异有统计学意义(P<0.05);治疗后,3组患者的6 min步行试验距离、左心室射血分数均较前增加,且C组患者最高,差异有统计学意义(P<0.05).结论 EECP联合强化降脂治疗能有效改善PCI术后患者的临床症状,增加活动耐量,提高心脏射血功能,抑制残余炎症因子的表达可能是其作用机制之一.
Clinical Efficacy of EECP Combined with Intensive Lipid-lowering on Patients After PCI and Its Effect on Residual Inflammatory Factors
Objective To observe the clinical efficacy of enhanced external counterpulsation(EECP)combined with intensive lipid-lowering on patients after percutaneous coronary intervention(PCI)and its effect on residual inflammatory factors.Methods One hundred and fifty patients who attended the Department of Cardiovascular Medicine of the Second Affiliated Hospital of Zhengzhou University from June 2021 to June 2023 and met the inclusion criteria were selected.They were randomly divided into three groups,A,B and C with 50 patients in each group respectively.Group A was given conventional drug therapy,group B was given conventional drug therapy and intensive lipid-lowering therapy,and group C was given conventional drug therapy and intensive lipid-lowering therapy and EECP treatment.The changes of clinical efficacy,activity tolerance,cardiac ejection function and residual inflammatory factors were compared between the three groups after treatment.Results After the treatment,the frequency and duration of angina attacks,residual inflammatory factor hypersensitive C-reactive protein and lipoprotein correlation phospholipase A2 levels of the three groups of patients were lower than those before treatment,and the indexes of Group C were significantly less than those of Groups A and B,with a statistically significant difference(P<0.05).After the treatment,the 6-minute walking experimental distance and left ventricular ejection fraction of the patients of the three groups were all increased than those before treatment,and the increase was more obvious in group C patients,with statistically significant differences(P<0.05).Conclusion EECP combined with intensive lipid-lowering can effectively improve the clinical symptoms,increase activity tolerance and improve cardiac ejection function of patients after PCI.Inhibition of the expression of the levels of residual inflammatory factors may be one of its mechanisms of the action.

percutaneous coronary interventionenhanced external counterpulsationintensive lipid loweringclinical efficacyresidual inflammation

熊保勇、郭广栗、赵佳佳、樊俊雅、王新宇、张辉

展开 >

郑州大学第二附属医院心脏康复中心,河南郑州 450014

经皮冠状动脉介入术 增强型体外反搏 强化降脂 临床疗效 残余炎症

河南省医学科技攻关计划联合共建项目河南省医学科技攻关计划联合共建项目

LHGJ20200408LHGJ20230353

2024

河南医学研究
河南省医学科学院

河南医学研究

影响因子:0.979
ISSN:1004-437X
年,卷(期):2024.33(10)
  • 25